Star Metro - Datametrex Announces Director Resignation and Appointment of Director

NYSE - LSE

RIO	1.52%	94.78	$
AZN	0.26%	159.2	$
RBGPF	1.17%	66.78	$
RYCEF	2.27%	18.47	$
NGG	-0.82%	76.48	$
GSK	-0.09%	46.5	$
CMSC	0.25%	19.95	$
RELX	2.46%	36.13	$
BCE	-6.28%	18.78	$
CMSD	0.02%	20.04	$
BP	-0.24%	46.25	$
BTI	0.13%	55.5	$
VOD	-5.91%	15.56	$
BCC	-0.88%	73.57	$
JRI	1.04%	10.62	$

Datametrex Announces Director Resignation and Appointment of Director

TECHNOLOGY 09.09.2026

Datametrex Announces Director Resignation and Appointment of Director

TORONTO, ON / ACCESS Newswire / September 9, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) announces that Paul Haber has resigned as a director of the Company effective September 2, 2026.

Text size:

The Company wishes to thank Paul Haber for his valuable contributions to the Company and wishes him success in his future endeavors.

The Company is also pleased to announce the appointment of Todd Talbot as a new member of the Board of Directors effective September 8, 2026.

Mr. Todd Talbot is a senior financial professional who brings 18 years of experience in financial due diligence, portfolio evaluation, risk management, private equity, venture capital, and corporate finance. Mr. Todd Talbot brings to the Company a proven track record conducting comprehensive investment vetting for institutions and presenting risk-adjusted financial analyses, valuation models, and governance strategies to boards, executive leadership, and high-net-worth stakeholders.

About Datametrex

Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

For more on Datametrex, please visit our Company website (www.datametrex.com).

For Additional Information

Michael Kron
CEO & Chairman
[email protected]
(416) 901-5611

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Datametrex AI Ltd.

View the original press release on ACCESS Newswire

S.Cloutier--SMC

Featured

Anthropic AI model sent fake murder tip to Philadelphia police

An artificial intelligence model developed by Anthropic submitted a fabricated tip about an unsolved homicide to Philadelphia police, authorities said Friday, criticizing the company for taking two months to report the incident.

Trump's 'super intelligence' rebrand to sell AI faces uphill battle

Donald Trump's campaign to rename artificial intelligence as "super intelligence" is unlikely to win over a wary public and could make matters worse, experts say, even as the US president threatens to treat holdouts as enemies.

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV

Not for distribution to U.S. news wire services or for dissemination in the United States

Regentis Biomaterials to Present at the 2026 ThinkEquity Conference on October 15 in New York City

HERZLIYA, IL / ACCESS Newswire / October 9, 2026 / Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced that Ehud Geller, Chief Executive Officer and Executive Chairman, will present at the 2026 ThinkEquity Conference on Thursday, October 15, 2026. Dr. Geller will be joined by Ori Gon, Chief Financial Officer, and both will be available for one-on-one meetings with investors.